BRG Borregaard

Borregaard ASA: Borregaard’s Capital Markets Day – The dawn of specialisation

Borregaard ASA: Borregaard’s Capital Markets Day – The dawn of specialisation

Borregaard’s Capital Markets Day (CMD) will take place today at Oslo Concert Hall, starting at 09:00 and ending at 12:30 CEST. The event can be followed via webcast (). The written material supporting the presentations is enclosed.

Key highlights - Borregaard CMD 2024:

  • The specialisation journey continues
  • BioSolutions – diversified portfolio attractively positioned for growth
  • BioMaterials – focus on regulated applications in tightening markets
  • Organic growth – top priority with market-driven innovation portfolio
  • Bio-based start-ups – leveraging expert knowledge, investing for the long term
  • Solid financial platform for accelerated growth

During the presentation, the President and CEO, Per A. Sørlie, will provide an update on key strategic considerations and the company’s strategic priorities.

The executive vice presidents in BioSolutions and Speciality Cellulose will give market updates focusing on attractive growth opportunities driven by sustainability and regulatory trends. The SVP R&D and Business development will elaborate on innovation, organic growth and bio-based investments.

The CFO, Per Bjarne Lyngstad, will comment on financial performance and Borregaard being positioned for accelerated growth.

Borregaard ASA

Sarpsborg, 18 September 2024

Contact:

Lotte Kvinlaug, Investor Relations Officer,

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.



Attachment



EN
18/09/2024

Underlying

BRGBorregaard

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE
Free
BRG BORREGAARD

Borregaard ASA: Reporting of transactions in Borregaard ASA's shares m...

Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025. The options will expire after five years (1 August 2030) and may be exercised in the last two years. The strike price of the options is NOK 219.31, based on the volume-weighted average share price (VWAP) over the last three trading days in July 2025 (29, 30 and 31 July), plus a 10% premium. The strike price wil...

August 1, 2025 1 EN
 PRESS RELEASE
Free
BRG BORREGAARD

Borregaard ASA: New CEO reinforces Borregaard’s commitment to speciali...

Borregaard ASA: New CEO reinforces Borregaard’s commitment to specialisation and value growth Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025). “Borregaard is well positioned with six production units, three R&D centres, and thirteen sales offices in key markets across Europe, the Americas, and Asia. We will continue to build on this solid foundation and our highly skilled organisation to advance our strategy of specialisation and value growth. Borregaard will continue to build on a strong legacy of specialisati...

August 1, 2025 1 EN
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
07/16/25 July 16, 2025 1 EN
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
07/16/25 July 16, 2025 1 EN
 PRESS RELEASE
Free
BRG BORREGAARD

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and BioMaterials increased while Fine Chemicals had a lower result. Continued growth in sales to agriculture was the main reason for the improved result in BioSolutions. In BioMaterials, the result increased due to higher sales prices, improved product mix and increased sales volume, partly offset by higher wood costs. Lower sales prices for b...

July 16, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch